Thermo Fisher and Celltrio bring first-in-kind
automation platform to address critical scale-up challenges in
biotherapeutics
BURLINGTON, Ontario – (February 6, 2023) — Thermo Fisher
Scientific, the world leader in serving science, and Celltrio, a leading manufacturer of
robotics-based solutions for the life sciences industry, have announced
their collaboration to bring a fully automated cell culture system to
biotherapeutics customers.
The collaboration will integrate the Thermo
Scientific Momentum workflow scheduling software with the Celltrio
RoboCell cell line automation platform to address the critical unmet market
need for high-throughput automated cell line culturing and maintenance.
Celltrio’s RoboCell systems
distributed in Europe will now use Momentum software for work scheduling and
data management. Thermo Fisher will also immediately take on exclusive
responsibility for sales, installation, and support of the RoboCell system
in Europe, with the possibility of extending into other geographies in the
future.
“Cell line scale-up challenges have long stifled the full potential of
biotherapy research. While researchers have been able to automate some
aspects of cell line production, full automation has been well out of
reach,” said Hansjoerg Haas, senior director and general manager, laboratory
automation, Thermo Fisher Scientific. “By collaborating with Celltrio, we’re
bringing together the capabilities that make fully automated cell line
culturing a reality. With the ability to effectively scale processes,
biotherapeutics customers can focus on getting their innovative therapies to
patients, paving the way to a better, healthier world.”
Charlie Duncheon, CEO and co-founder, Celltrio, Inc. said, “The complementary
expertise of Thermo Fisher and Celltrio offers a clear, powerful opportunity
to help customers overcome a pressing roadblock. By offering Thermo Fisher’s
intuitive Momentum workflow scheduling software with Celltrio’s end-to-end
automation RoboCell platform, we can expand the RoboCell reach and amplify
the impact of both solutions for biotherapeutics customers, benefitting the
biopharma market and human health.”
With the Momentum workflow scheduling software, RoboCell users may define,
execute, and monitor processes and workflows with an easy-to-use interface.
The software’s intelligent data-driven decision-making capabilities and
bi-directional communication also enable secure connectivity and
traceability while ensuring laboratories boost their performance.
For more information about the Thermo Scientific Momentum Workflow Scheduling
Software, please visit: https://www.thermofisher.com/order/catalog/product/MOMENTUM
For more information about the Celltrio RoboCell cell line automation
platform, please visit: https://www.celltrio.com/robocell
About Thermo Fisher Scientific
Thermo Fisher Scientific
Inc. is the world leader in serving science, with annual revenue of
more than $40 billion. Our Mission is to enable our customers to make
the world healthier, cleaner and safer. Whether our customers are
accelerating life sciences research, solving complex analytical challenges,
increasing productivity in their laboratories, improving patient health
through diagnostics or the development and manufacture of life-changing
therapies, we are here to support them. Our global team delivers an
unrivaled combination of innovative technologies, purchasing convenience and
pharmaceutical services through our industry-leading brands, including
Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity
Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
MEDIA:
Piatra Marani
Thermo Fisher Scientific
+1 657-229-9083
piatra.marani@thermofisher.com